Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Tract Calculi I: Introduction01:28

Urinary Tract Calculi I: Introduction

1.1K
Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...
1.1K
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

863
Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
863
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

402
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
402
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

764
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
764
Urinary Tract Calculi V: Nursing Management01:28

Urinary Tract Calculi V: Nursing Management

496
AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...
496
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

582
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
582

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Private equity acquisitions and cancer care: nothing to see here? Not so fast.

Journal of the National Cancer Institute·2026
Same author

Baseline Urinary Calcium and the Efficacy of Thiazide Diuretics for Kidney Stone Prevention.

The Journal of urology·2026
Same author

Primary Care Involvement and Health Care Utilization Among Patients With End-Stage Kidney Disease.

JAMA network open·2026
Same author

Hemodialysis Facilities, Vascular Access Surgeons, and Central Venous Catheter Use: A Retrospective Cohort Study.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same author

Facility Variation of Follow-Up Imaging Practices Among U.S. Veterans for Urinary Stone Disease.

Journal of endourology·2026
Same author

Reply to Editorial Comment on "Laboratory Abnormalities Associated With the Use of Preventive Pharmacological Therapy for Urinary Stone Disease".

Urology·2026

Related Experiment Video

Updated: May 5, 2026

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis
07:45

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis

Published on: February 9, 2021

2.9K

Adherence to Potassium Citrate, Changes in 24-hour Stone Risk Parameters, and Recurrent Kidney Stone Events.

Joseph J Crivelli1, Mary K Oerline2, Naim M Maalouf3

  • 1Department of Urology, University of Alabama at Birmingham Heersink School of Medicine and Birmingham Veterans Affairs Medical Center, Birmingham, AL, USA.

Kidney360
|March 3, 2026
PubMed
Summary

Accurate monitoring of potassium citrate adherence is crucial for preventing recurrent urinary stones. While percentage of days covered (PDC) predicts stone recurrence, changes in urinary potassium better reflect medication effectiveness.

More Related Videos

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
11:30

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro

Published on: June 2, 2022

1.8K
Author Spotlight: Developing a Bedside Protocol for Kidney and Genitourinary Ultrasonography
03:19

Author Spotlight: Developing a Bedside Protocol for Kidney and Genitourinary Ultrasonography

Published on: June 21, 2024

3.0K

Related Experiment Videos

Last Updated: May 5, 2026

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis
07:45

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis

Published on: February 9, 2021

2.9K
A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
11:30

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro

Published on: June 2, 2022

1.8K
Author Spotlight: Developing a Bedside Protocol for Kidney and Genitourinary Ultrasonography
03:19

Author Spotlight: Developing a Bedside Protocol for Kidney and Genitourinary Ultrasonography

Published on: June 21, 2024

3.0K

Area of Science:

  • Nephrology
  • Urology
  • Pharmacology

Background:

  • Patient adherence to preventive pharmacologic therapy (PPT) for urinary stone disease (USD) is suboptimal.
  • Effective adherence monitoring is essential for improving PPT outcomes in USD.
  • This study investigates potassium citrate adherence measures and their association with urinary parameters and stone recurrence.

Purpose of the Study:

  • To assess the association between different potassium citrate adherence measures and changes in 24-hour urine parameters.
  • To evaluate the relationship between adherence measures and the risk of recurrent urinary stone events.

Main Methods:

  • Retrospective cohort study of Medicare enrollees with USD, hypocitraturia or low urine pH, and potassium citrate prescription.
  • Two adherence measures: percentage of days covered (PDC) and change in urinary potassium divided by dose (ΔK/dose).
  • Analysis of covariance and Cox models used to assess associations with urine parameters and stone recurrence.

Main Results:

  • 63.6% adherence by PDC (≥80%) and 49.1% by ΔK/dose (≥0.5).
  • ΔK/dose showed stronger association with increased urinary citrate and pH compared to PDC.
  • Lower PDC (<80%) was linked to a higher risk of recurrent stone events (HR 1.431), while ΔK/dose was not significantly associated.

Conclusions:

  • Clinically significant differences exist between potassium citrate adherence measures.
  • ΔK/dose is a better indicator of medication's effect on urinary citrate and pH.
  • Only PDC adherence was a significant predictor of recurrent urinary stone events.